Volume 101, Issue 3

Search all International Journal of Hematology articles

March 2015

Including PIH Article on Molecular pathogenesis and treatment strategies of adult leukemia

Filter by

Volume:

Sort by

Date published:

New to old Old to new

14 articles in this issue

Donald Metcalf, ‘Father of CSF’ (1929–2014)
Shigetaka Asano
Obituary 24 February 2015 Pages: 209 - 210
Cryptococcosis in bone marrow following treatment for Hodgkin lymphoma
Nuri Yigit
William W. Wu
Wayne Tam
Images in Hematology 01 January 2015 Pages: 211 - 212
Genetic and molecular characterization of myelodysplastic syndromes and related myeloid neoplasms
Bhumika Patel
Cassandra Hirsch
Jaroslaw P. Maciejewski
Progress in Hematology 18 February 2015 Pages: 213 - 218
Molecular pathogenesis of CLL and its evolution
David Rodríguez
Gabriel Bretones
Carlos López-Otín
Progress in Hematology 29 January 2015 Pages: 219 - 228
Molecular pathogenesis of atypical CML, CMML and MDS/MPN-unclassifiable
Katerina Zoi
Nicholas C. P. Cross
Progress in Hematology 12 September 2014 Pages: 229 - 242
Allogeneic hematopoietic cell transplantation for acute myeloid leukemia during first complete remission: a clinical perspective
Masamitsu Yanada
Progress in Hematology 12 September 2014 Pages: 243 - 254
Treatment patterns and clinical outcomes in patients with chronic immune thrombocytopenia (ITP) switched to eltrombopag or romiplostim
David J. Kuter
Cynthia Macahilig
Melea Ward
Original Article 14 January 2015 Pages: 255 - 263
The Effect of Preoperative Vitamin K on the INR in Bridging Therapy
Ashrei Bayewitz
Barbara Scorziello
Henny Heisler Billett
Original Article 31 January 2015 Pages: 264 - 267
Significance of lymphocyte counts at diagnosis in the management of ITP: the relationship between lymphocyte counts and treatment success in H. pylori-infected patients
Akihisa Nagata
Naohiro Sekiguchi
Naoki Takezako
Original Article 28 January 2015 Pages: 268 - 272
Clinical features and treatment outcomes of primary cutaneous B-cell lymphoma: a single-center analysis in South Korea
Moon Jin Kim
Min Eui Hong
Won Seog Kim
Original Article 01 January 2015 Pages: 273 - 278
Long-term follow-up of homoharringtonine plus all-trans retinoic acid-based induction and consolidation therapy in newly diagnosed acute promyelocytic leukemia
Ying Wang
Dong Lin
Jianxiang Wang
Original Article 07 January 2015 Pages: 279 - 285
Phase 1 study in Japan of siltuximab, an anti-IL-6 monoclonal antibody, in relapsed/refractory multiple myeloma
Kenshi Suzuki
Michinori Ogura
Koho Iizuka
Original Article 06 February 2015 Pages: 286 - 294
A multinational, open-label, phase 2 study of ruxolitinib in Asian patients with myelofibrosis: Japanese subset analysis
Kenji Oritani
Shinichiro Okamoto
Koichi Akashi
Original Article 01 February 2015 Pages: 295 - 304
Mutations in Bruton’s tyrosine kinase impair IgA responses
Noriko Mitsuiki
Xi Yang
Tomohiro Morio
Original Article 15 January 2015 Pages: 305 - 313

Volume 101, Issue 3

Donald Metcalf, ‘Father of CSF’ (1929–2014)

Cryptococcosis in bone marrow following treatment for Hodgkin lymphoma

Genetic and molecular characterization of myelodysplastic syndromes and related myeloid neoplasms

Molecular pathogenesis of CLL and its evolution

Molecular pathogenesis of atypical CML, CMML and MDS/MPN-unclassifiable

Allogeneic hematopoietic cell transplantation for acute myeloid leukemia during first complete remission: a clinical perspective

Treatment patterns and clinical outcomes in patients with chronic immune thrombocytopenia (ITP) switched to eltrombopag or romiplostim

The Effect of Preoperative Vitamin K on the INR in Bridging Therapy

Significance of lymphocyte counts at diagnosis in the management of ITP: the relationship between lymphocyte counts and treatment success in H. pylori-infected patients

Clinical features and treatment outcomes of primary cutaneous B-cell lymphoma: a single-center analysis in South Korea

Long-term follow-up of homoharringtonine plus all-trans retinoic acid-based induction and consolidation therapy in newly diagnosed acute promyelocytic leukemia

Phase 1 study in Japan of siltuximab, an anti-IL-6 monoclonal antibody, in relapsed/refractory multiple myeloma

A multinational, open-label, phase 2 study of ruxolitinib in Asian patients with myelofibrosis: Japanese subset analysis

Mutations in Bruton’s tyrosine kinase impair IgA responses

Navigation